| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7349 |
| Human Intestinal Absorption | HIA+ | 0.9502 |
| Caco-2 Permeability | Caco2- | 0.5792 |
| P-glycoprotein Substrate | Non-substrate | 0.8146 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7934 |
| Non-inhibitor | 0.8586 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8943 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6673 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.6458 |
| CYP450 2D6 Substrate | Non-substrate | 0.8985 |
| CYP450 3A4 Substrate | Non-substrate | 0.6669 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8781 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7061 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9216 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7082 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.5332 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5242 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9828 |
| Non-inhibitor | 0.8383 |
| AMES Toxicity | Non AMES toxic | 0.7872 |
| Carcinogens | Non-carcinogens | 0.8019 |
| Fish Toxicity | High FHMT | 0.7917 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.7691 |
| Honey Bee Toxicity | Low HBT | 0.7891 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.6357 |
| Carcinogenicity (Three-class) | Non-required | 0.5336 |